BCTrastuzumabEmtansineRule2
type: Library
node role: treeRoot
id:
  v: BCTrastuzumabEmtansineRule2
text:
  status:
    v: extensions
  div:
    v: Metadata Title Trastuzumab Emtansine（晚期乳癌）給付規定-Trastuzumab Emtansine Rule2 Version 1.0.0 Status Draft Description 此 Library 為乳癌（晚期乳癌）患者於申請使用 Trastuzumab Emtansine 之給付檢核條件。 Type logic-library from http://terminology.hl7.org/CodeSystem/library-type Parameters Parameter None Library Content CQL Content //晚期乳癌_Trastuzumab Emtansine給付規定 library BCTrastuzumabEmtansineRule2 version '1.0.0' using FHIR version '4.0.1' include FHIRHelpers version '4.0.1' called FHIRHelpers include BCCodeConcept version '1.0.0' called CodeConcept include BCReusable version '1.0.0' called Reusable context Patient //============================================ // 主要規定一：初次使用條件 //============================================ /*規則1*/ //1條件1:限單獨使用於先前未使用過本藥品 define "1條件1=限單獨使用於先前未使用過本藥品": not Reusable."HasPriorMedicationUse"(CodeConcept.L01FD03, CodeConcept.L01FD03) //1條件2:HER2過度表現(IHC3+或FISH+)之轉移性乳癌病人作為二線治療 define "檢驗檢查-HER2過度表現(IHC3+或FISH+)": Reusable."HasHER2OverexpressionTest" define "基因檢測-HER2過度表現(IHC3+或FISH+)": Reusable."HasHER2OverexpressionGene" define "HER2過度表現(IHC3+或FISH+)": "檢驗檢查-HER2過度表現(IHC3+或FISH+)" or "基因檢測-HER2過度表現(IHC3+或FISH+)" define "3個月內有檢查報告": Reusable."HasRecentMolecularReport"("本次申請起始日期", 90) define "癌症分期分數或結果為M>=1": exists ( [Observation] O where exists ( O.code.coding Cdg where Cdg.code = '399390009' and Cdg in CodeConcept.SNOMED ) and O.value is not null and O.value is FHIR.string and Matches((O.value as FHIR.string).value, '.*M[^0].*') ) define "3個月內影像報告": Reusable."HasRecentImageReport"("本次申請起始日期", 90) define "ICD代碼檢核_布林值": Reusable."ICD-10使用C50" define "用藥線別檢核_布林值": Reusable."用藥線別=2" define "1條件2=HER2過度表現(IHC3+或FISH+)之轉移性乳癌病人作為二線治療": Reusable."ICD-10使用C50" and Reusable."用藥線別=2" and "HER2過度表現(IHC3+或FISH+)" and "癌症分期分數或結果為M>=1" and ( (not "3個月內有檢查報告" and not "3個月內影像報告") or ("3個月內有檢查報告" and "3個月內影像報告") ) //1條件3:並同時符合下列情形 //I.之前分別接受過trastuzumab與一種taxane藥物治療，或其合併療法，或pertuzumab與trastuzumab與一種taxane藥物治療。 //Ⅱ.之前已經接受過轉移性癌症治療，或在輔助療法治療期間或完成治療後6個月內癌症復發。 //Ⅲ.合併有主要臟器(不包含骨及軟組織)轉移。 //1條件3…
url:
  v: https://nhicore.nhi.gov.tw/cql/Library/BCTrastuzumabEmtansineRule2
  l: BCTrastuzumabEmtansineRule2
version:
  v: 1.0.0
name:
  v: BCTrastuzumabEmtansineRule2
title:
  v: Trastuzumab Emtansine（晚期乳癌）給付規定-Trastuzumab Emtansine Rule2
status:
  v: draft
type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/library-type
      l: library-type
    code:
      v: logic-library
date:
  v: 2026-04-12
description:
  v: 此 Library 為乳癌（晚期乳癌）患者於申請使用 Trastuzumab Emtansine 之給付檢核條件。
content:
  content type:
    v: text/cql
content:
  content type:
    v: application/elm+xml
content:
  content type:
    v: application/elm+json